Sign In

Christoph Herrmann

Director Business Planning Analysis at Novartis

Christoph Herrmann is a finance professional currently working at Novartis as Director of Business Planning and Analysis for Hematology and CAR-T.3 He has an international background and a proven track record in driving financial initiatives.1

Herrmann holds a Master's degree in Business Administration from Martin-Luther-Universität.1 His career experience includes roles in corporate finance, with a previous position as Executive Director in Corporate Finance and M&A Advisory at UBS in Zürich, Switzerland.2

At Novartis, Herrmann is part of the finance team, likely focusing on strategic planning and financial analysis for the company's hematology and CAR-T cell therapy divisions. His role involves utilizing his expertise in business planning to support Novartis's efforts in these critical areas of medical research and treatment.3

Highlights

Aug 25 · haematologica.org
An open-label, phase I/II trial to determine the maximum tolerated ...
Discovery, Preclinical Characterization, and Early Clinical Activity of ...
A Conversation Between Susanne Schaffert and Ken Herrmann

Related Questions

What are Christoph Herrmann's main responsibilities at Novartis?
How long has Christoph Herrmann been with Novartis?
What is Christoph Herrmann's educational background?
What projects is Christoph Herrmann currently working on at Novartis?
How has Christoph Herrmann contributed to the field of hematology?
Christoph Herrmann
Add to my network

Location

Hoboken, New Jersey, United States